GHIF Announcements

31 January 2017

PATH, Clarus, and GHIF Announce $25 Million Anthelmintic Collaboration

Innovative financing arrangement will improve treatment of intestinal worms, affecting more than 1 billion people globally

21 December 2016

KfW Development Bank Publishes GHIF Project Update

Report indicates GHIF is performing against original impact investment objectives

30 March 2016

Access Bio Added to GHIF Portfolio as 6th Investment

$8 million of convertible note proceeds will finance the purchase and installation of new manufacturing equipment for Access Bio’s rapid diagnostic test products

13 January 2016

GHIF Makes $6 Million Loan to Atomo Diagnostics

The investment will support continued rollout of Atomo’s award-winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance

8 January 2016

GHIF-Backed EuBiologics Earns WHO Endorsement for Euvichol

WHO prequalification of Euvichol will double the availability of approved oral cholera vaccine in 2016

8 March 2015

$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness

If approved, moxidectin is expected to significantly accelerate the eradication of this terrible neglected disease

27 August 2014

GHIF Leads $7.5 Million Investment into Cholera Vaccine Manufacturer

Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers 

22 July 2014

GHIF Invests in Epistem to Finance New TB Diagnostic

Investment will support the roll-out of Epistem’s Genedrive® molecular diagnostic platform as the company’s tuberculosis assay enters pivotal field trials in key developing world locations

GHIF in the News

25 May 2017

This fund seeks a traditional return and grantlike impact for global health R&D

Staff at the Bill & Melinda Gates Foundation and J.P. Morgan said they hope the Global Health Investment Fund will demonstrate that it is possible to generate social impact, reduce costs to health care systems and deliver financial returns to investors at the same time.

13 December 2016 :: Barron’s Penta Daily

How to Make Money With Impact Investments

“Social-impact investing might often be about the intangible benefits provided to society. When it comes to your portfolio, however, you want to be sure the financial returns delivered aren’t intangible, but very real.”

29 November 2016 :: Inside Philanthropy

Can Investing in Rapid Self-Testing Disrupt the HIV/AIDS Mortality Curve?

Earlier this year, the Global Health Investment Fund (GHIF) announced that it was making a $6 million loan to Atomo Diagnostics, a point-of-care diagnostics company improving rapid testing platforms

5 October 2016 :: Bloomberg Radio

The Bloomberg Advantage: LaBelle on Social Impact on Medicine

Curt Labelle, Managing Partner at the Global Health Investment Fund, discussing working to save lives, while also lowering healthcare costs in the developing world

2 October 2013 :: Jamie Dimon

Innovating and Investing for Life-Saving Impact

GHIF will give individual and institutional investors their first ever opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries

23 September 2013 :: The Globe and Mail

Billionaires team up to fight disease in developing world

Public-private partnerships are increasingly the norm when it comes to tackling vexing global health challenges

23 September 2013 :: JPMorgan Chase & Co.

New Investment Fund Will Advance Late-Stage Vaccines and other Global Health Technologies

JPMorgan Chase, the Bill & Melinda Gates Foundation and partners announce successful capital raise for first-of-its-kind investment product

@theGHIF Twitter Feed

GHIF Buzz on Twitter